6. TOXICOKINETICS

Toxicokinetics is the study of how a toxin enters the body, distributes through tissues, is metabolized, and is eventually eliminated. It reflects what the body does to a toxic substance, especially when exposure levels exceed those used therapeutically. Understanding toxicokinetics is essential for predicting the onset, severity, and duration of poisoning and for selecting appropriate management strategies.

What Is Toxicokinetics?

The term originates from pharmacokinetics, which studies drug movement through the body. Toxicokinetics extends this concept to include drugs taken in toxic doses, environmental chemicals, occupational exposures, and xenobiotics that pose health hazards. The core processes are similar—absorption, distribution, biotransformation, and excretion—but the outcomes differ because toxic doses often overwhelm the body’s physiological systems.

1. Absorption

Absorption refers to the entry of a toxic substance into the bloodstream. Toxins may be absorbed through the gastrointestinal tract, skin, lungs, eyes, or parenteral routes. Factors that influence absorption include:

  • Physicochemical properties of the toxin (solubility, polarity, pH)
  • Integrity of the skin or mucosa
  • Presence of food or other substances in the stomach
  • Local blood flow

Rapid and extensive absorption may result in early and severe toxic manifestations.

2. Distribution

After absorption, toxins distribute through the bloodstream into tissues and organs. Distribution determines which organs are most affected. Lipid-soluble toxins may accumulate in the brain and adipose tissue, whereas water-soluble toxins remain mostly in extracellular fluid.

Factors Affecting Distribution

  • Protein binding capacity
  • Lipid solubility
  • Blood–tissue partitioning
  • Capillary permeability

Toxins with high protein binding remain in circulation longer and may be released gradually, prolonging toxicity.

3. Biotransformation

Biotransformation, also called metabolism, converts toxins into more water-soluble compounds for elimination. This occurs primarily in the liver through phase I and phase II enzyme systems. However, metabolism can sometimes increase toxicity, as seen with paracetamol, where toxic metabolites cause hepatic injury.

Effects of Biotransformation

  • Detoxification (conversion to inactive metabolites)
  • Activation (formation of toxic metabolites)
  • Saturation of metabolic pathways in overdose

Co-ingested substances, liver disease, and enzyme-inducing drugs can significantly influence biotransformation.

4. Excretion

Excretion removes toxins or their metabolites from the body. The kidneys, liver, lungs, and skin play important roles in excretion. Renal excretion through glomerular filtration, tubular secretion, and reabsorption is the most common route.

Factors Affecting Excretion

  • Urine pH (ion trapping)
  • Renal function status
  • Biliary secretion and enterohepatic circulation

Altered excretion may prolong toxicity and increase systemic burden.

Factors Determining Toxicity Severity

The harmful effects of a toxin depend on how much reaches target tissues and how long it stays there. Important determinants include:

  • Concentration and duration of toxin at the entry site
  • Efficiency and extent of absorption
  • Distribution pattern and tissue affinity
  • Nature of metabolites formed during biotransformation
  • Ability to cross cell membranes and interact with cellular components such as DNA
  • Storage of toxins in tissues (e.g., lead in bones)
  • Rate and route of excretion
  • Patient factors such as age, health, and organ function

Infants, elderly patients, and individuals with chronic illnesses often experience more severe effects due to compromised metabolic or excretory capacities.

Interrelationship of ADME Processes

The four toxicokinetic processes—absorption, distribution, biotransformation, and elimination—are interconnected. Once absorbed, toxins travel through blood, distribute into tissues, undergo metabolic reactions, and finally get excreted. Disturbance in any of these stages can significantly modify toxicity.

Toxicokinetic Parameters

1. Area Under the Concentration–Time Curve (AUC)

AUC represents the total toxin exposure over time. A larger AUC indicates greater systemic absorption and potentially higher toxicity.

2. Volume of Distribution (Vd)

Vd estimates the degree to which a toxin spreads into various body compartments. A high Vd suggests extensive tissue penetration, often making dialysis ineffective.

3. Clearance

Clearance refers to the efficiency of the body in removing toxins. It may be expressed as total body clearance or organ-specific clearance, such as renal clearance.

4. Plasma Half-Life

Half-life is the time required for plasma concentration of the toxin to decrease by half. Toxins with long half-lives may accumulate and cause prolonged toxicity.

Detailed Notes:

For PDF style full-color notes, open the complete study material below:

RAW VERSION:

PATH: PHARMD/ PHARMD NOTES/ PHARMD FOURTH YEAR NOTES/ CLINICAL TOXICOLOGY/ TOXICOKINETICS.

Share your love